Acta Pharmaceutica Sinica B
|
2025, 15(9): 4972-4972
• Correction •
Author correction to “Microbial metabolite 3-indolepropionic acid alleviated PD pathologies by decreasing enteric glia cell gliosis via suppressing IL-13Rα1 related signaling pathways” [Acta Pharm Sin B 15 (2025) 2024-2038]
Full
Meiyu Shang1, Jingwen Ning1, Caixia Zang1, Jingwei Ma1, Yang Yang1, Zhirong Wan2, Jing Zhao2, Yueqi Jiang1, Qiuzhu Chen1, Yirong Dong1, Jinrong Wang1, Fangfang Li1, Xiuqi Bao1, Dan Zhang1
Affiliations
1 State Key Laboratory of Bioactive Substrate and Function of Natural Medicine, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China;
2 Department of Neurology, Aerospace Center Hospital, Beijing 100049, China
doi: 10.1016/j.apsb.2025.06.017
Outline
Meiyu Shang, Jingwen Ning, Caixia Zang, Jingwei Ma, Yang Yang, Zhirong Wan, Jing Zhao, Yueqi Jiang, Qiuzhu Chen, Yirong Dong, Jinrong Wang, Fangfang Li, Xiuqi Bao, Dan Zhang.
Author correction to “Microbial metabolite 3-indolepropionic acid alleviated PD pathologies by decreasing enteric glia cell gliosis via suppressing IL-13Rα1 related signaling pathways” [Acta Pharm Sin B 15 (2025) 2024-2038][J].
Acta Pharmaceutica Sinica B,
2025
, 15
(9)
: 4972
-4972
.
DOI: 10.1016/j.apsb.2025.06.017
Year 2025 volume 15 Issue 9
PDF
7
4
Cite this Article
BibTeX
Article Info
doi: 10.1016/j.apsb.2025.06.017